Crispr Therapeutics Ag CRSP स्टॉक पूर्वानुमान
Crispr Therapeutics Ag के लिए AI-संचालित मूल्य भविष्यवाणी और विश्लेषण · अपडेट किया गया मा 31, 2026
AI 90-दिवसीय पूर्वानुमान
होल्ड
7 दिन
30 दिन
90 दिन
AI विश्वास: 11% स्पिअरमैन सहसंबंध
मार्च 31, 2026
CRSP का सटीक मूल्य लक्ष्य देखें
4,000+ स्टॉक्स के लिए AI भविष्यवाणियां अनलॉक करने हेतु मुफ्त खाता बनाएं
Google से मुफ्त साइन अप करें✓ मुफ़्त खाता · ✓ 30-दिवसीय परीक्षण · ✓ कभी भी रद्द करें
मूल्य चार्ट
चार्ट लोड हो रहा है...
मुख्य आंकड़े
बाज़ार पूंजीकरण
$4.25B
P/E अनुपात
-12.1x
P/B अनुपात
2.21x
EPS
$-5.40
ROE
15.4%
नेट मार्जिन
-69265.6%
राजस्व
$3M
करंट रेशो
19.88x
D/E अनुपात
0.10x
हमारे बारे में Crispr Therapeutics Ag
Crispr Therapeutics Ag (CRSP) Life Sciences क्षेत्र में संचालित है, विशेष रूप से Biological Products, (No Diagnostic Substances) उद्योग में. कंपनी में लगभग 304 कर्मचारी कार्यरत हैं.
CRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland. The company does business as CRISPR Therapeutics, Inc. in the United States. It was one of the first companies formed to utilize the CRISPR gene editing platform to develop medicines for the treatment of various rare and common diseases. The company has approximately 500 employees and has offices in Zug, Switzerland, Boston, Massachusetts, San Francisco, California and London, United Kingdom. Its manufacturing facility in Framingham, Massachusetts won the …
नवीनतम समाचार
Biological Products, (No Diagnostic Substances) समकक्ष कंपनियां
| कंपनी | टिकर | AI सिग्नल | बाज़ार पूंजीकरण | P/E |
|---|---|---|---|---|
| Acumen Pharmaceuticals, Inc. | ABOS | ██% | $170M | -1.9x |
| Abpro Holdings, Inc. | ABP | ██% | $310K | -x |
| Arcellx, Inc. | ACLX | ██% | $6.65B | -74.1x |
| Alpha Cognition Inc. | ACOG | ██% | $116M | -x |
| Adaptimmune Therapeutics Plc | ADAP | ██% | $77M | -13.2x |
| Adma Biologics, Inc. | ADMA | ██% | $2.18B | 14.8x |
| Adaptive Biotechnologies Corp | ADPT | ██% | $1.98B | -4.6x |
| Adverum Biotechnologies, Inc. | ADVM | ██% | $95M | -1.8x |
| Agenus Inc | AGEN | ██% | $114M | 995.1x |
| Agentix Corp. | AGTX | ██% | $2M | -x |
| Aim Immunotech Inc. | AIM | ██% | $2M | -0.5x |
| Aim Immunotech Inc. | AIMI | ██% | $1M | -x |
| Alector, Inc. | ALEC | ██% | $223M | -1.2x |
| Aligos Therapeutics, Inc. | ALGS | ██% | $41M | -19.2x |
| Allogene Therapeutics, Inc. | ALLO | ██% | $509M | -1.4x |
| Alvotech | ALVO | ██% | $1.07B | -x |
| Amgen Inc | AMGN | ██% | $189.58B | 24.6x |
| Apogee Therapeutics, Inc. | APGE | ██% | $5.38B | -20.5x |
| Aptose Biosciences Inc. | APTOF | ██% | $4M | -x |
| Argenx Se | ARGX | ██% | $41.93B | -x |
| Armata Pharmaceuticals, Inc. | ARMP | ██% | $315M | -1.0x |
| Artiva Biotherapeutics, Inc. | ARTV | ██% | $133M | -x |
| Leonabio, Inc. | ATHA | ██% | $23M | -0.2x |
| Atara Biotherapeutics, Inc. | ATRA | ██% | $35M | 1.1x |
| Atyr Pharma Inc | ATYR | ██% | $76M | -3.6x |
| Aura Biosciences, Inc. | AURA | ██% | $425M | -4.9x |
| Autolus Therapeutics Plc | AUTL | ██% | $386M | -x |
| Anavex Life Sciences … | AVXL | ██% | $261M | -17.3x |
| Bioatla, Inc. | BCAB | ██% | $13M | -1.1x |
| Biocardia, Inc. | BCDA | ██% | $12M | -0.6x |
| Brainstorm Cell Therapeutics … | BCLI | ██% | $8M | -4.9x |
| Biocryst Pharmaceuticals Inc | BCRX | ██% | $2.37B | 9.0x |
| Black Diamond Therapeutics, … | BDTX | ██% | $116M | 5.2x |
| Beam Therapeutics Inc. | BEAM | ██% | $2.23B | -12.6x |
| Biogen Inc. | BIIB | ██% | $27.54B | 21.3x |
| Biontech Se | BNTX | ██% | $21.43B | -x |
| Cabaletta Bio, Inc. | CABA | ██% | $286M | -1.6x |
| Candel Therapeutics, Inc. | CADL | ██% | $328M | -4.6x |
| C4 Therapeutics, Inc. | CCCC | ██% | $228M | -2.6x |
| Cidara Therapeutics, Inc. | CDTX | ██% | $6.49B | -1.0x |
| Creative Medical Technology … | CELZ | ██% | $7M | -3.4x |
| Cero Therapeutics Holdings, … | CERO | ██% | $720K | -x |
| Cullinan Therapeutics, Inc. | CGEM | ██% | $847M | -4.1x |
| Compugen Ltd | CGEN | ██% | $188M | -x |
| Cg Oncology, Inc. | CGON | ██% | $5.16B | -x |
| Cognition Therapeutics Inc | CGTX | ██% | $68M | -0.5x |
| Coherus Oncology, Inc. | CHRS | ██% | $265M | 1.6x |
| Calidi Biotherapeutics, Inc. | CLDI | ██% | $2M | -0.9x |
| Cellectis S.A. | CLLS | ██% | $319M | -x |
| Compass Therapeutics, Inc. | CMPX | ██% | $909M | -4.8x |
| Mosaic Immunoengineering Inc. | CPMV | ██% | $5M | -x |
| Caribou Biosciences, Inc. | CRBU | ██% | $142M | -1.5x |
| Cardiff Oncology, Inc. | CRDF | ██% | $106M | -4.0x |
| Cardiol Therapeutics Inc. | CRDL | ██% | $136M | -x |
| Curis Inc | CRIS | ██% | $20M | -0.3x |
| Crispr Therapeutics Ag | CRSP | ██% | $4.25B | -12.1x |
| Champions Oncology, Inc. | CSBR | ██% | $80M | 32.9x |
| Cel Sci Corp | CVM | ██% | $26M | -0.9x |
| Dbv Technologies S.A. | DBVT | ██% | $1.13B | -3.3x |
| Dbv Technologies S.A. | DBVTF | ██% | $10K | -x |
| Ginkgo Bioworks Holdings, … | DNA | ██% | $319M | -13.9x |
| Denali Therapeutics Inc. | DNLI | ██% | $2.82B | -8.7x |
| Precision Biosciences Inc | DTIL | ██% | $131M | -2.2x |
| Dyadic International Inc | DYAI | ██% | $31M | -7.3x |
| Editas Medicine, Inc. | EDIT | ██% | $218M | -0.8x |
| Elutia Inc. | ELUT | ██% | $44M | 0.8x |
| Engene Holdings Inc. | ENGN | ██% | $414M | 3.7x |
| Entera Bio Ltd. | ENTX | ██% | $51M | 8.5x |
| Viskase Holdings, Inc. | ENZN | ██% | $4M | -x |
| Estrella Immunopharma, Inc. | ESLA | ██% | $42M | -3.1x |
| Evaxion A/S | EVAX | ██% | $31M | -x |
| Exelixis, Inc. | EXEL | ██% | $11.01B | 14.1x |
| Exozymes Inc. | EXOZ | ██% | $61M | -x |
| Fate Therapeutics Inc | FATE | ██% | $122M | -1.3x |
| 4d Molecular Therapeutics, … | FDMT | ██% | $438M | -3.0x |
| Fennec Pharmaceuticals Inc. | FENC | ██% | $210M | 1758.3x |
| Finch Therapeutics Group, … | FNCH | ██% | $15M | -0.1x |
| Futuretech Ii Acquisition … | FTII | ██% | $52M | -x |
| Futuretech Ii Acquisition … | FTIIU | ██% | $14M | -x |
| Gilead Sciences, Inc. | GILD | ██% | $169.20B | 19.9x |
| Monte Rosa Therapeutics, … | GLUE | ██% | $1.32B | 59.5x |
| Genenta Science S.P.A. | GNTA | ██% | $16M | -x |
| Green Planet Bio … | GPLB | ██% | $340K | -x |
| Halozyme Therapeutics, Inc. | HALO | ██% | $7.32B | 23.1x |
| Humacyte, Inc. | HUMA | ██% | $128M | -3.3x |
| Immunitybio, Inc. | IBRX | ██% | $6.74B | -3.6x |
| Inhibikase Therapeutics, Inc. | IKT | ██% | $194M | -1.0x |
| Immunocore Holdings Plc | IMCR | ██% | $1.48B | -x |
| Immatics N.V. | IMTX | ██% | $1.25B | -x |
| Immunovant, Inc. | IMVT | ██% | $4.85B | -14.5x |
| In8bio, Inc. | INAB | ██% | $13M | -x |
| Inhibrx Biosciences, Inc. | INBX | ██% | $873M | -6.8x |
| Mink Therapeutics, Inc. | INKT | ██% | $45M | -1.5x |
| Inmune Bio, Inc. | INMB | ██% | $30M | -2.5x |
| Intensity Therapeutics, Inc. | INTS | ██% | $14M | -2.2x |
| Iovance Biotherapeutics, Inc. | IOVA | ██% | $1.45B | -4.5x |
| Century Therapeutics, Inc. | IPSC | ██% | $365M | -0.7x |
| Invivyd, Inc. | IVVD | ██% | $367M | -0.4x |
| Jasper Therapeutics, Inc. | JSPR | ██% | $25M | -3.2x |
| Kalaris Therapeutics, Inc. | KLRS | ██% | $121M | -x |
| Klotho Neurosciences, Inc. | KLTO | ██% | $56M | -x |
| Kodiak Sciences Inc. | KOD | ██% | $2.35B | -2.5x |
| Krystal Biotech, Inc. | KRYS | ██% | $7.21B | 35.2x |
| Kymera Therapeutics, Inc. | KYMR | ██% | $6.46B | -17.8x |
| Kyverna Therapeutics, Inc. | KYTX | ██% | $458M | -x |
| Ladrx Corp | LADX | ██% | $20K | -x |
| Lineage Cell Therapeutics, … | LCTX | ██% | $360M | -4.7x |
| Lenz Therapeutics, Inc. | LENZ | ██% | $357M | -6.7x |
| Liminatus Pharma, Inc. | LIMN | ██% | $10M | -x |
| Lexeo Therapeutics, Inc. | LXEO | ██% | $385M | -0.4x |
| Maze Therapeutics, Inc. | MAZE | ██% | $1.43B | -x |
| Mesoblast Ltd | MESO | ██% | $1.90B | -x |
| Meiragtx Holdings Plc | MGTX | ██% | $596M | -3.4x |
| Metagenomi Therapeutics, Inc. | MGX | ██% | $50M | -x |
| Molecular Partners Ag | MOLN | ██% | $160M | -x |
| Moderna, Inc. | MRNA | ██% | $20.02B | -3.2x |
| Neurocrine Biosciences Inc | NBIX | ██% | $12.80B | 26.7x |
| Nkgen Biotech, Inc. | NKGN | ██% | $2M | -0.1x |
| Neumora Therapeutics, Inc. | NMRA | ██% | $399M | -3.9x |
| Novavax Inc | NVAX | ██% | $1.51B | 3.4x |
| Ocugen, Inc. | OCGN | ██% | $547M | -4.3x |
| Outlook Therapeutics, Inc. | OTLK | ██% | $22M | -0.2x |
| Palisade Bio, Inc. | PALI | ██% | $291M | -0.2x |
| Passage Bio, Inc. | PASG | ██% | $22M | -0.6x |
| Vaxcyte, Inc. | PCVX | ██% | $7.62B | -20.4x |
| Biomx Inc. | PHGE | ██% | $8M | 1.5x |
| Pluri Inc. | PLUR | ██% | $34M | -1.4x |
| Protalix Biotherapeutics, Inc. | PLX | ██% | $173M | 41.2x |
| Pharmacyte Biotech, Inc. | PMCB | ██% | $8M | 0.3x |
| Prime Medicine, Inc. | PRME | ██% | $617M | -1.5x |
| Prokidney Corp. | PROK | ██% | $526M | -x |
| Qiagen N.V. | QGEN | ██% | $9.11B | -x |
| Quince Therapeutics, Inc. | QNCX | ██% | $5M | -1.7x |
| Qrons Inc. | QRON | ██% | $150K | -x |
| Replimune Group, Inc. | REPL | ██% | $602M | -3.8x |
| Repligen Corp | RGEN | ██% | $6.61B | 135.2x |
| Regenxbio Inc. | RGNX | ██% | $418M | -1.8x |
| Relay Therapeutics, Inc. | RLAY | ██% | $1.84B | -2.0x |
| Revolution Medicines, Inc. | RVMD | ██% | $19.08B | -11.1x |
| Recursion Pharmaceuticals, Inc. | RXRX | ██% | $1.58B | -4.7x |
| Sab Biotherapeutics, Inc. | SABS | ██% | $273M | 20.6x |
| Sana Biotechnology, Inc. | SANA | ██% | $740M | -2.1x |
| Scilex Holding Co | SCLX | ██% | $47M | -0.4x |
| Scinai Immunotherapeutics Ltd. | SCNI | ██% | $2M | -287.8x |
| Sangamo Therapeutics, Inc | SGMO | ██% | $82M | -1.6x |
| Solid Biosciences Inc. | SLDB | ██% | $715M | -0.9x |
| Silexion Therapeutics Corp | SLXN | ██% | $4M | -x |
| Senti Biosciences, Inc. | SNTI | ██% | $24M | -1.1x |
| Scholar Rock Holding … | SRRK | ██% | $5.22B | -18.5x |
| Surrozen, Inc./De | SRZN | ██% | $343M | -0.5x |
| Sutro Biopharma, Inc. | STRO | ██% | $356M | -1.0x |
| Protara Therapeutics, Inc. | TARA | ██% | $278M | -2.1x |
| Tarsus Pharmaceuticals, Inc. | TARS | ██% | $2.87B | -12.4x |
| Tc Biopharm (Holdings) … | TCBPY | ██% | $10K | -x |
| Tscan Therapeutics, Inc. | TCRX | ██% | $57M | -4.6x |
| Bio-Techne Corp | TECH | ██% | $8.20B | 101.1x |
| Tectonic Therapeutic, Inc. | TECX | ██% | $587M | -8.9x |
| Instil Bio, Inc. | TIL | ██% | $56M | -1.1x |
| Tenaya Therapeutics, Inc. | TNYA | ██% | $159M | -2.5x |
| Tourmaline Bio, Inc. | TRML | ██% | $1.23B | -3.5x |
| Taysha Gene Therapies, … | TSHA | ██% | $1.26B | -3.0x |
| Titan Pharmaceuticals Inc | TTNP | ██% | $6M | -0.5x |
| Tevogen Bio Holdings … | TVGN | ██% | $17M | -x |
| Twist Bioscience Corp | TWST | ██% | $2.85B | -12.6x |
| Voyager Acquisition Corp./Cayman … | VACH | ██% | $372M | 41.3x |
| Voyager Acquisition Corp./Cayman … | VACHU | ██% | $68M | 6.7x |
| Valneva Se | VALN | ██% | $548M | -x |
| Vericel Corp | VCEL | ██% | $1.61B | 97.7x |
| Vir Biotechnology, Inc. | VIR | ██% | $1.47B | -2.0x |
| Vivosim Labs, Inc. | VIVS | ██% | $4M | -x |
| Vor Biopharma Inc. | VOR | ██% | $738M | -0.6x |
| Vaxart, Inc. | VXRT | ██% | $146M | 8.9x |
| Voyager Therapeutics, Inc. | VYGR | ██% | $238M | 570.6x |
| Windtree Therapeutics Inc … | WINT | ██% | $320K | -0.4x |
| X4 Pharmaceuticals, Inc | XFOR | ██% | $375M | 6.4x |
| Zeo Scientifix, Inc. | ZEOX | ██% | $17M | -x |
| Zivo Bioscience, Inc. | ZIVO | ██% | $26M | -31.3x |
| Zura Bio Ltd | ZURA | ██% | $565M | -x |
अक्सर पूछे जाने वाले प्रश्न
-
क्या Crispr Therapeutics Ag खरीदने के लिए अच्छा स्टॉक है?
हमारा AI Crispr Therapeutics Ag का दैनिक विश्लेषण करता है। नवीनतम सिफारिश के लिए ऊपर सिग्नल देखें। निवेश करने से पहले हमेशा अपना शोध स्वयं करें।
-
Crispr Therapeutics Ag की भविष्यवाणियां कितनी सटीक हैं?
हमारा AI इस स्टॉक के लिए 11% स्पिअरमैन सहसंबंध प्राप्त करता है, दैनिक विश्लेषित 4,000+ स्टॉक्स में 67%+ औसत सटीकता के साथ।
-
पूर्वानुमान कितनी बार अपडेट होते हैं?
Crispr Therapeutics Ag के पूर्वानुमान नवीनतम बाजार डेटा और AI मॉडल का उपयोग करके दैनिक अपडेट किए जाते हैं।
स्मार्ट निवेश के लिए तैयार हैं?
AI-संचालित स्टॉक भविष्यवाणियों का उपयोग करने वाले हजारों निवेशकों से जुड़ें
मुफ्त साइन अप करें✓ मुफ़्त खाता · ✓ 4,000+ स्टॉक्स · ✓ दैनिक अपडेट
Crispr Therapeutics Ag का गहन विश्लेषण खोज रहे हैं?
Intratio पर पूर्ण संस्थागत-स्तर का विश्लेषण देखें →AI भविष्यवाणियां ऐतिहासिक पैटर्न पर आधारित हैं और निवेश निर्णयों का एकमात्र आधार नहीं होनी चाहिए। पिछला प्रदर्शन भविष्य के परिणामों की गारंटी नहीं देता। हमेशा अपना शोध स्वयं करें।